Table 1. Transthoracic echocardiography on unanesthetized sham, tumor, or tumor plus resveratrol treatment in age-matched mice 16 days after tumor implantation (±SE).

A one-way ANOVA was performed to determine significance.

	Control N=8	Tumor N=4	Tumor + 500R N=4	Control + 500R N=4
Body Weight (g)	21.8 ± 0.4	20.4 ± 1.1	21.6 ± 0.8	20.6 ± 0.4
HR (bpm)	651 ± 9	617 ± 27	640 ± 13	659 ± 13
LVEDD (mm)	2.63 ± 0.09	2.95 ± 0.08*	2.82 ± 0.13	2.50 ± 0.07
LVESD (mm)	1.11 ± 0.05	1.35 ± 0.07	1.19 ± 0.10	1.08 ± 0.06
LV %EF	88.97 ± 0.46	85.78 ± 2.78	88.64 ± 1.86	88.20 ± 0.94
LV Vol; d (ml)	25.9 ± 2.2	33.8 ± 2.2	30.6 ± 3.5	22.8 ± 1.5
LV Vol; s (ml)	2.9 ± 0.3	4.7 ± 0.7	3.5 ± 0.8	1.7 ± 1.5

BW, body weight; LV, left ventricle; HR, heart rate; LVEDD, LV end diastolic dimension; LVESD, LV end systolic dimension; LV EF%=[ (LV Vol;d-LV Vol;s/LV Vol;d )*100];LV Vol; d, LV volume in diastole; LV Vol;s, LV volume in systole; LV Post W.

^*p<0.05 vs Control, Tumor + 500R, and Control + 500R.